{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:54:12Z","timestamp":1781639652884,"version":"3.54.5"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"UConn Research Enhancement Program and UConn Health Department of Cell Biology\/Center for Vascular Biology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The breast tumor microenvironment (TME) is a complex milieu composed of many factors contributing to breast cancer (BC) heterogeneity and therapeutic resistance. Aberrant tumor vasculature in the TME limits nutrient and drug delivery, inhibits anti-tumor immunity, and contributes to a lack of cancer therapy efficacy. Utilizing publicly available scRNA-seq datasets, this study characterizes differences between normal breast and breast tumor endothelial cells (EC), provides insights into tumor endothelial cell subtypes, endothelial anergy, and identifies novel, tumor-specific vascular therapeutic targets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Gene expression data from normal and breast tumor tissue samples were integrated, and the EC subset was extracted via canonical gene marker expression. The EC subset was clustered and evaluated for cell subtypes and differentially expressed genes (DEG). Normal EC (NEC) and tumor EC (TEC) markers were further assessed for correlation to bulk gene expression and patient survival outcomes in cBioPortal and Kaplan\u2013Meier Plotter. Cell type gene expression specificity was evaluated in the 3CA single-cell RNA-seq datasets across multiple cancers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>This analysis revealed differences in NEC and TEC subtype populations. Breast NEC contained similar proportions of venule and capillary populations, while breast TEC demonstrated a majority of the venule subtype. Further, TEC venules were phenotypically distinct from the NEC venules. Consistent with endothelial anergy, suppression of the key adhesion protein SELE was noted, as well as several pro-inflammatory cytokines including IL6, CCL2, and CXCL8, likely downstream of aberrant NF-kB signaling. Differential gene expression analysis identified several TEC specific up-regulated genes compared to NEC, including CLEC14a, IGFBP4, EMCN, and ADM5. CLEC14a, EMCN, and ADM5 were further validated in the single-cell Curated Cancer Cell Atlas (3CA) to be highly specific to the endothelial cell clusters across multiple tumor types, while IGFBP4 was diversely expressed in endothelial, fibroblast, and some malignant cell types. ADM5, a novel tumor vascular marker, was enhanced in TEC venules and less so in arteriole or capillaries. High expression of ADM5 was associated with poor breast cancer patient survival in the basal PAM50 cancer subtype compared to normal and luminal subtypes. Further, across multiple cancer types, high ADM5 expression was associated with reduced patient survival in anti-PD1- and anti-CTLA4-treated patients but not in anti-PDL1-treated patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Integration of single-cell RNA-seq data identified an anergic-like response in breast TEC and multiple, highly specific markers to TEC not found in normal breast tissue. CLEC14a and EMCN were validated as TEC markers, extending their annotation in breast TEC, and ADM5 identified as a novel TEC marker in breast and other cancers. Moreover, as ADM5 is associated with reduced patient overall survival, this data suggests that a better understanding of ADM5 and other TEC-specific response pathways may provide novel approaches to reactivate anergic TECs and lead to effective therapeutic interventions for cancer patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13058-026-02249-0","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T07:04:40Z","timestamp":1772521480000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transcriptomic profiles from normal and tumor tissue samples reveal distinct venule populations and novel tumor endothelial cell markers in breast cancer"],"prefix":"10.1186","volume":"28","author":[{"given":"Kathryn N.","family":"Phoenix","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijender","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick A.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin P.","family":"Claffey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"issue":"2","key":"2249_CR1","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s10549-021-06431-0","volume":"191","author":"BE Wilson","year":"2022","unstructured":"Wilson BE, Gorrini C, Cescon DW. Breast cancer immune microenvironment: from pre-clinical models to clinical therapies. Breast Cancer Res Treat. 2022;191(2):257\u201367.","journal-title":"Breast Cancer Res Treat"},{"key":"2249_CR2","doi-asserted-by":"crossref","unstructured":"Abadjian MCZ, Edwards WB, Anderson CJ. Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy. Adv Exp Med Biol. 2017;229\u201357.","DOI":"10.1007\/978-3-319-67577-0_15"},{"issue":"1","key":"2249_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2019.152729","volume":"216","author":"PIR Franco","year":"2020","unstructured":"Franco PIR, Rodrigues AP, Menezes LBde, Miguel MP. Tumor microenvironment components: allies of cancer progression. Pathol Res Pract. 2020;216(1):152729.","journal-title":"Pathol Res Pract"},{"issue":"12","key":"2249_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-022-01782-0","volume":"39","author":"K Kawaguchi","year":"2022","unstructured":"Kawaguchi K, Maeshima Y, Toi M. Tumor immune microenvironment and systemic response in breast cancer. Med Oncol. 2022;39(12):208.","journal-title":"Med Oncol"},{"issue":"45","key":"2249_CR5","doi-asserted-by":"publisher","first-page":"5904","DOI":"10.1038\/onc.2008.271","volume":"27","author":"TL Whiteside","year":"2008","unstructured":"Whiteside TL. The tumor microenvironment and its role in promoting tumor growth. Oncogene. 2008;27(45):5904\u201312.","journal-title":"Oncogene"},{"issue":"5","key":"2249_CR6","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.","journal-title":"Cell"},{"key":"2249_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.656364","volume":"12","author":"K Khalaf","year":"2021","unstructured":"Khalaf K, Hana D, Chou JTT, Singh C, Mackiewicz A, Kaczmarek M. Aspects of the tumor microenvironment involved in immune resistance and drug resistance. Front Immunol. 2021;12:656364.","journal-title":"Front Immunol"},{"issue":"1","key":"2249_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12(1):31\u201346.","journal-title":"Cancer Discov"},{"issue":"1","key":"2249_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57\u201370.","journal-title":"Cell"},{"issue":"6801","key":"2249_CR10","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/35025220","volume":"407","author":"P Carmeliet","year":"2000","unstructured":"Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000;407(6801):249\u201357.","journal-title":"Nature"},{"issue":"6","key":"2249_CR11","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrc1093","volume":"3","author":"G Bergers","year":"2003","unstructured":"Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer. 2003;3(6):401\u201310.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"2249_CR12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10456-008-9099-z","volume":"11","author":"J Nagy","year":"2008","unstructured":"Nagy J, Benjamin L, Zeng H, Dvorak A, Dvorak H. Vascular permeability, vascular hyperpermeability and angiogenesis. Angiogenesis. 2008;11(2):109\u201319.","journal-title":"Angiogenesis"},{"issue":"7","key":"2249_CR13","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s10585-012-9500-6","volume":"29","author":"JA Nagy","year":"2012","unstructured":"Nagy JA, Dvorak HF. Heterogeneity of the tumor vasculature: the need for new tumor blood vessel type-specific targets. Clin Exp Metastasis. 2012;29(7):657\u201362.","journal-title":"Clin Exp Metastasis"},{"key":"2249_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2013.00211","volume":"3","author":"S Azzi","year":"2013","unstructured":"Azzi S, Hebda JK, Gavard J. Vascular permeability and drug delivery in cancers. Front Oncol. 2013;3:211.","journal-title":"Front Oncol"},{"issue":"8","key":"2249_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13081912","volume":"13","author":"D Belotti","year":"2021","unstructured":"Belotti D, Pinessi D, Taraboletti G. Alternative vascularization mechanisms in tumor resistance to therapy. Cancers. 2021;13(8):1912.","journal-title":"Cancers"},{"issue":"3","key":"2249_CR16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nri.2017.145","volume":"18","author":"Y Huang","year":"2018","unstructured":"Huang Y, Kim BYS, Chan CK, Hahn SM, Weissman IL, Jiang W. Improving immune\u2013vascular crosstalk for cancer immunotherapy. Nat Rev Immunol. 2018;18(3):195\u2013203.","journal-title":"Nat Rev Immunol"},{"key":"2249_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00766","volume":"8","author":"L Nagl","year":"2020","unstructured":"Nagl L, Horvath L, Pircher A, Wolf D. Tumor endothelial cells (TECs) as potential immune directors of the tumor microenvironment \u2013 new findings and future perspectives. Front Cell Dev Biol. 2020;8:766.","journal-title":"Front Cell Dev Biol"},{"issue":"11","key":"2249_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12113380","volume":"12","author":"AG Solimando","year":"2020","unstructured":"Solimando AG, Summa SD, Vacca A, Ribatti D. Cancer-associated angiogenesis: the endothelial cell as a checkpoint for immunological patrolling. Cancers. 2020;12(11):3380.","journal-title":"Cancers"},{"key":"2249_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.613114","volume":"11","author":"RA Khouzam","year":"2021","unstructured":"Khouzam RA, Brodaczewska K, Filipiak A, Zeinelabdin NA, Buart S, Szczylik C, et al. Tumor hypoxia regulates immune escape\/invasion: influence on angiogenesis and potential impact of hypoxic biomarkers on cancer therapies. Front Immunol. 2021;11:613114.","journal-title":"Front Immunol"},{"key":"2249_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.828875","volume":"13","author":"RA Khouzam","year":"2022","unstructured":"Khouzam RA, Zaarour RF, Brodaczewska K, Azakir B, Venkatesh GH, Thiery J, et al. The effect of hypoxia and hypoxia-associated pathways in the regulation of antitumor response: friends or foes? Front Immunol. 2022;13:828875.","journal-title":"Front Immunol"},{"key":"2249_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1387198","volume":"12","author":"Y Xu","year":"2024","unstructured":"Xu Y, Miller CP, Tykodi SS, Akilesh S, Warren EH. Signaling crosstalk between tumor endothelial cells and immune cells in the microenvironment of solid tumors. Front Cell Dev Biol. 2024;12:1387198.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"2249_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01460-1","volume":"8","author":"ZL Liu","year":"2023","unstructured":"Liu ZL, Chen HH, Zheng LL, Sun LP, Shi L. Angiogenic signaling pathways and anti-angiogenic therapy for cancer. Signal Transduct Target Ther. 2023;8(1):198.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"2249_CR23","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s10456-023-09876-7","volume":"26","author":"AC Dudley","year":"2023","unstructured":"Dudley AC, Griffioen AW. Pathological angiogenesis: mechanisms and therapeutic strategies. Angiogenesis. 2023;26(3):313\u201347.","journal-title":"Angiogenesis"},{"issue":"1","key":"2249_CR24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12964-022-00838-y","volume":"20","author":"MJ Ansari","year":"2022","unstructured":"Ansari MJ, Bokov D, Markov A, Jalil AT, Shalaby MN, Suksatan W, et al. Cancer combination therapies by angiogenesis inhibitors; a comprehensive review. Cell Commun Signal. 2022;20(1):49.","journal-title":"Cell Commun Signal"},{"key":"2249_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.812916","volume":"11","author":"S Jain","year":"2022","unstructured":"Jain S, Chalif EJ, Aghi MK. Interactions between anti-angiogenic therapy and immunotherapy in glioblastoma. Front Oncol. 2022;11:812916.","journal-title":"Front Oncol"},{"key":"2249_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2022.100849","volume":"64","author":"M Huang","year":"2022","unstructured":"Huang M, Lin Y, Wang C, Deng L, Chen M, Assaraf YG, et al. New insights into antiangiogenic therapy resistance in cancer: mechanisms and therapeutic aspects. Drug Resist Updat. 2022;64:100849.","journal-title":"Drug Resist Updat"},{"issue":"10043","key":"2249_CR27","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/S0140-6736(15)01088-0","volume":"388","author":"GC Jayson","year":"2016","unstructured":"Jayson GC, Kerbel R, Ellis LM, Harris AL. Antiangiogenic therapy in oncology: current status and future directions. Lancet. 2016;388(10043):518\u201329.","journal-title":"Lancet"},{"issue":"8","key":"2249_CR28","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41571-021-00496-y","volume":"18","author":"ZR Huinen","year":"2021","unstructured":"Huinen ZR, Huijbers EJM, van Beijnum JR, Nowak-Sliwinska P, Griffioen AW. Anti-angiogenic agents: overcoming tumour endothelial cell anergy and improving immunotherapy outcomes. Nat Rev Clin Oncol. 2021;18(8):527\u201340.","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"2249_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11030316","volume":"11","author":"Y Katayama","year":"2019","unstructured":"Katayama Y, Uchino J, Chihara Y, Tamiya N, Kaneko Y, Yamada T, et al. Tumor neovascularization and developments in therapeutics. Cancers. 2019;11(3):316.","journal-title":"Cancers"},{"key":"2249_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.838133","volume":"13","author":"NM Ayoub","year":"2022","unstructured":"Ayoub NM, Jaradat SK, Al-Shami KM, Alkhalifa AE. Targeting angiogenesis in breast cancer: current evidence and future perspectives of novel anti-angiogenic approaches. Front Pharmacol. 2022;13:838133.","journal-title":"Front Pharmacol"},{"issue":"10","key":"2249_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/cells10102712","volume":"10","author":"JK Hennigs","year":"2021","unstructured":"Hennigs JK, Matuszcak C, Trepel M, K\u00f6rbelin J. Vascular endothelial cells: heterogeneity and targeting approaches. Cells. 2021;10(10):2712.","journal-title":"Cells"},{"issue":"18","key":"2249_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20184411","volume":"20","author":"A Kr\u00fcger-Genge","year":"2019","unstructured":"Kr\u00fcger-Genge A, Blocki A, Franke RP, Jung F. Vascular endothelial cell biology: an update. Int J Mol Sci. 2019;20(18):4411.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2249_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14361","volume":"8","author":"E Dejana","year":"2017","unstructured":"Dejana E, Hirschi KK, Simons M. The molecular basis of endothelial cell plasticity. Nat Commun. 2017;8(1):14361.","journal-title":"Nat Commun"},{"issue":"4","key":"2249_CR34","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.cmet.2020.03.009","volume":"31","author":"K Rohlenova","year":"2020","unstructured":"Rohlenova K, Goveia J, Garc\u00eda-Caballero M, Subramanian A, Kalucka J, Treps L, et al. Single-cell RNA sequencing maps endothelial metabolic plasticity in pathological angiogenesis. Cell Metab. 2020;31(4):862-877.e14.","journal-title":"Cell Metab"},{"issue":"1","key":"2249_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-021-02632-x","volume":"4","author":"A Fouladzadeh","year":"2021","unstructured":"Fouladzadeh A, Dorraki M, Min KKM, Cockshell MP, Thompson EJ, Verjans JW, et al. The development of tumour vascular networks. Commun Biol. 2021;4(1):1111.","journal-title":"Commun Biol"},{"issue":"16","key":"2249_CR36","doi-asserted-by":"publisher","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","volume":"30","author":"NM Anderson","year":"2020","unstructured":"Anderson NM, Simon MC. The tumor microenvironment. Curr Biol. 2020;30(16):R921\u20135.","journal-title":"Curr Biol"},{"issue":"2","key":"2249_CR37","doi-asserted-by":"publisher","first-page":"e136655","DOI":"10.1172\/JCI136655","volume":"131","author":"BM Kahn","year":"2021","unstructured":"Kahn BM, Lucas A, Alur R, Wengyn MD, Schwartz GW, Li J, et al. The vascular landscape of human cancer. J Clin Investig. 2021;131(2):e136655.","journal-title":"J Clin Investig"},{"issue":"2","key":"2249_CR38","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/boc.202100015","volume":"114","author":"M Hegde","year":"2022","unstructured":"Hegde M, Bhat SM, Guruprasad KP, Moka R, Ramachandra L, Satyamoorthy K, et al. Human breast tumor derived endothelial cells exhibit distinct biological properties. Biol Cell. 2022;114(2):73\u201385.","journal-title":"Biol Cell"},{"issue":"1","key":"2249_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33052-y","volume":"13","author":"V Geldhof","year":"2022","unstructured":"Geldhof V, Rooij LPMHde, Sokol L, Amersfoort J, Schepper MD, Rohlenova K, et al. Single cell atlas identifies lipid-processing and immunomodulatory endothelial cells in healthy and malignant breast. Nat Commun. 2022;13(1):5511.","journal-title":"Nat Commun"},{"issue":"8","key":"2249_CR40","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/s41591-018-0096-5","volume":"24","author":"D Lambrechts","year":"2018","unstructured":"Lambrechts D, Wauters E, Boeckx B, Aibar S, Nittner D, Burton O, et al. Phenotype molding of stromal cells in the lung tumor microenvironment. Nat Med. 2018;24(8):1277\u201389.","journal-title":"Nat Med"},{"issue":"1","key":"2249_CR41","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12943-022-01597-7","volume":"21","author":"I Heidegger","year":"2022","unstructured":"Heidegger I, Fotakis G, Offermann A, Goveia J, Daum S, Salcher S, et al. Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4\/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer. Mol Cancer. 2022;21(1):132.","journal-title":"Mol Cancer"},{"key":"2249_CR42","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.omtn.2021.03.017","volume":"24","author":"C Li","year":"2021","unstructured":"Li C, Guo L, Li S, Hua K. Single-cell transcriptomics reveals the landscape of intra-tumoral heterogeneity and transcriptional activities of ECs in CC. Mol Ther Nucleic Acids. 2021;24:682\u201394.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"13","key":"2249_CR43","doi-asserted-by":"publisher","first-page":"10945","DOI":"10.18632\/oncotarget.23760","volume":"9","author":"Z Sun","year":"2017","unstructured":"Sun Z, Wang CY, Lawson DA, Kwek S, Velozo HG, Owyong M, et al. Single-cell RNA sequencing reveals gene expression signatures of breast cancer-associated endothelial cells. Oncotarget. 2017;9(13):10945\u201361.","journal-title":"Oncotarget"},{"key":"2249_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/CMAR.S316700","volume":"14","author":"Y Fan","year":"2022","unstructured":"Fan Y, He S. The characteristics of tumor microenvironment in triple negative breast cancer. Cancer Manag Res. 2022;14:1\u201317.","journal-title":"Cancer Manag Res"},{"issue":"1","key":"2249_CR45","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ccell.2023.12.012","volume":"42","author":"SL Shiao","year":"2024","unstructured":"Shiao SL, Gouin KH, Ing N, Ho A, Basho R, Shah A, et al. Single-cell and spatial profiling identify three response trajectories to pembrolizumab and radiation therapy in triple negative breast cancer. Cancer Cell. 2024;42(1):70-84.e8.","journal-title":"Cancer Cell"},{"issue":"9","key":"2249_CR46","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","volume":"53","author":"SZ Wu","year":"2021","unstructured":"Wu SZ, Al-Eryani G, Roden DL, Junankar S, Harvey K, Andersson A, et al. A single-cell and spatially resolved atlas of human breast cancers. Nat Genet. 2021;53(9):1334\u201347.","journal-title":"Nat Genet"},{"issue":"11","key":"2249_CR47","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020107333","volume":"40","author":"B Pal","year":"2021","unstructured":"Pal B, Chen Y, Vaillant F, Capaldo BD, Joyce R, Song X, et al. A single\u2010cell RNA expression atlas of normal, preneoplastic and tumorigenic states in the human breast. EMBO J. 2021;40(11):e107333.","journal-title":"EMBO J"},{"issue":"13","key":"2249_CR48","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao Y, Hao S, Andersen-Nissen E, Mauck WM, Zheng S, Butler A, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184(13):3573-3587.e29.","journal-title":"Cell"},{"issue":"7","key":"2249_CR49","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM, et al. Comprehensive integration of single-cell data. Cell. 2019;177(7):1888-1902.e21.","journal-title":"Cell"},{"issue":"1","key":"2249_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0888-1","volume":"17","author":"T Ilicic","year":"2016","unstructured":"Ilicic T, Kim JK, Kolodziejczyk AA, Bagger FO, McCarthy DJ, Marioni JC, et al. Classification of low quality cells from single-cell RNA-seq data. Genome Biol. 2016;17(1):29.","journal-title":"Genome Biol"},{"issue":"2","key":"2249_CR51","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao Y, Stuart T, Kowalski MH, Choudhary S, Hoffman P, Hartman A, et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat Biotechnol. 2024;42(2):293\u2013304.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"2249_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0844-5","volume":"16","author":"G Finak","year":"2015","unstructured":"Finak G, McDavid A, Yajima M, Deng J, Gersuk V, Shalek AK, et al. MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data. Genome Biol. 2015;16(1):278.","journal-title":"Genome Biol"},{"issue":"43","key":"2249_CR53","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"2249_CR54","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, et al. PGC-1\u03b1-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34(3):267\u201373.","journal-title":"Nat Genet"},{"issue":"6","key":"2249_CR55","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsd\u00f3ttir H, Ghandi M, Mesirov JP, Tamayo P. The molecular signatures database hallmark gene set collection. Cell Syst. 2015;1(6):417\u201325.","journal-title":"Cell Syst"},{"issue":"5","key":"2249_CR56","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401\u20134.","journal-title":"Cancer Discov"},{"issue":"23","key":"2249_CR57","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1158\/0008-5472.CAN-23-0816","volume":"83","author":"I Bruijn","year":"2023","unstructured":"Bruijn I, Kundra R, Mastrogiacomo B, Tran TNgoc, Sikina L, Mazor T, et al. Analysis and visualization of longitudinal genomic and clinical data from the AACR project GENIE biopharma collaborative in cBioPortal. Cancer Res. 2023;83(23):3861\u20137.","journal-title":"Cancer Res"},{"issue":"269","key":"2249_CR58","doi-asserted-by":"publisher","first-page":"p11","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):p11.","journal-title":"Sci Signal."},{"issue":"7403","key":"2249_CR59","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10983","volume":"486","author":"C Curtis","year":"2012","unstructured":"Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 2012;486(7403):346\u201352.","journal-title":"Nature"},{"issue":"10","key":"2249_CR60","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"K Chang","year":"2013","unstructured":"Chang K, Creighton CJ, Davis C, Donehower L, Drummond J, Wheeler D, et al. The cancer genome atlas pan-cancer analysis project. Nat Genet. 2013;45(10):1113\u201320.","journal-title":"Nat Genet"},{"issue":"7965","key":"2249_CR61","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41586-023-06130-4","volume":"618","author":"A Gavish","year":"2023","unstructured":"Gavish A, Tyler M, Greenwald AC, Hoefflin R, Simkin D, Tschernichovsky R, et al. Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours. Nature. 2023;618(7965):598\u2013606.","journal-title":"Nature"},{"issue":"9","key":"2249_CR62","doi-asserted-by":"publisher","first-page":"nwae231","DOI":"10.1093\/nsr\/nwae231","volume":"11","author":"J Li","year":"2024","unstructured":"Li J, Wang D, Tang F, Ling X, Zhang W, Zhang Z. Pan-cancer integrative analyses dissect the remodeling of endothelial cells in human cancers. Natl Sci Rev. 2024;11(9):nwae231.","journal-title":"Natl Sci Rev"},{"issue":"8","key":"2249_CR63","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41568-023-00591-5","volume":"23","author":"Q Zeng","year":"2023","unstructured":"Zeng Q, Mousa M, Nadukkandy AS, Franssens L, Alnaqbi H, Alshamsi FY, et al. Understanding tumour endothelial cell heterogeneity and function from single-cell omics. Nat Rev Cancer. 2023;23(8):544\u201364.","journal-title":"Nat Rev Cancer"},{"issue":"19","key":"2249_CR64","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.1182\/blood-2010-02-270819","volume":"116","author":"R Toro","year":"2010","unstructured":"Toro R, Prahst C, Mathivet T, Siegfried G, Kaminker JS, Larrivee B, et al. Identification and functional analysis of endothelial tip cell\u2013enriched genes. Blood. 2010;116(19):4025\u201333.","journal-title":"Blood"},{"key":"2249_CR65","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.55589","volume":"9","author":"CS Helker","year":"2020","unstructured":"Helker CS, Eberlein J, Wilhelm K, Sugino T, Malchow J, Schuermann A, et al. Apelin signaling drives vascular endothelial cells toward a pro-angiogenic state. Elife. 2020;9:e55589.","journal-title":"Elife"},{"issue":"1","key":"2249_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25960-2","volume":"12","author":"JW Squair","year":"2021","unstructured":"Squair JW, Gautier M, Kathe C, Anderson MA, James ND, Hutson TH, et al. Confronting false discoveries in single-cell differential expression. Nat Commun. 2021;12(1):5692.","journal-title":"Nat Commun"},{"key":"2249_CR67","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.yjmcc.2014.09.017","volume":"77","author":"A Yamauchi","year":"2014","unstructured":"Yamauchi A, Sakurai T, Kamiyoshi A, Ichikawa-Shindo Y, Kawate H, Igarashi K, et al. Functional differentiation of RAMP2 and RAMP3 in their regulation of the vascular system. J Mol Cell Cardiol. 2014;77:73\u201385.","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"2249_CR68","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1172\/JCI33022","volume":"118","author":"Y Ichikawa-Shindo","year":"2008","unstructured":"Ichikawa-Shindo Y, Sakurai T, Kamiyoshi A, Kawate H, Iinuma N, Yoshizawa T, et al. The GPCR modulator protein RAMP2 is essential for angiogenesis and vascular integrity. J Clin Investig. 2008;118(1):29\u201339.","journal-title":"J Clin Investig"},{"issue":"4","key":"2249_CR69","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.4049\/jimmunol.168.4.1618","volume":"168","author":"TW Liang","year":"2002","unstructured":"Liang TW, Chiu HH, Gurney A, Sidle A, Tumas DB, Schow P, et al. Vascular endothelial-junctional adhesion molecule (VE-JAM)\/JAM 2 interacts with T, NK, and dendritic cells through JAM 3. J Immunol. 2002;168(4):1618\u201326.","journal-title":"J Immunol"},{"issue":"4","key":"2249_CR70","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s10456-018-9627-4","volume":"21","author":"MG Dallinga","year":"2018","unstructured":"Dallinga MG, Yetkin-Arik B, Kayser RP, Vogels IMC, Nowak-Sliwinska P, Griffioen AW, et al. IGF2 and IGF1R identified as novel tip cell genes in primary microvascular endothelial cell monolayers. Angiogenesis. 2018;21(4):823\u201336.","journal-title":"Angiogenesis"},{"issue":"9","key":"2249_CR71","doi-asserted-by":"publisher","first-page":"5904","DOI":"10.1074\/jbc.M113.480038","volume":"289","author":"MW Zimmerman","year":"2014","unstructured":"Zimmerman MW, McQueeney KE, Isenberg JS, Pitt BR, Wasserloos KA, Homanics GE, et al. Protein-tyrosine phosphatase 4A3 (PTP4A3) promotes vascular endothelial growth factor signaling and enables endothelial cell motility*. J Biol Chem. 2014;289(9):5904\u201313.","journal-title":"J Biol Chem"},{"issue":"1","key":"2249_CR72","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10456-011-9251-z","volume":"15","author":"MJ Siemerink","year":"2012","unstructured":"Siemerink MJ, Klaassen I, Vogels IMC, Griffioen AW, Noorden CJFV, Schlingemann RO. CD34 marks angiogenic tip cells in human vascular endothelial cell cultures. Angiogenesis. 2012;15(1):151\u201363.","journal-title":"Angiogenesis"},{"issue":"9","key":"2249_CR73","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1161\/CIRCRESAHA.114.303265","volume":"114","author":"KM Michalik","year":"2014","unstructured":"Michalik KM, You X, Manavski Y, Doddaballapur A, Z\u00f6rnig M, Braun T, et al. Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth. Circ Res. 2014;114(9):1389\u201397.","journal-title":"Circ Res"},{"issue":"4","key":"2249_CR74","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s10456-015-9473-6","volume":"18","author":"A Schuermann","year":"2015","unstructured":"Schuermann A, Helker CSM, Herzog W. Metallothionein 2 regulates endothelial cell migration through transcriptional regulation of vegfc expression. Angiogenesis. 2015;18(4):463\u201375.","journal-title":"Angiogenesis"},{"issue":"1","key":"2249_CR75","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13046-020-01641-8","volume":"39","author":"J Liu","year":"2020","unstructured":"Liu J, Gao L, Zhan N, Xu P, Yang J, Yuan F, et al. Hypoxia induced ferritin light chain (FTL) promoted epithelia mesenchymal transition and chemoresistance of glioma. J Exp Clin Cancer Res. 2020;39(1):137.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"2249_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-025-00896-8","volume":"9","author":"H Tang","year":"2025","unstructured":"Tang H, Cai Y, Yang M, Tang S, Huang Q, Li H, et al. Single-cell and spatial transcriptomics reveals the key role of MCAM+ tip-like endothelial cells in osteosarcoma metastasis. NPJ Precis Oncol. 2025;9(1):104.","journal-title":"NPJ Precis Oncol"},{"issue":"9","key":"2249_CR77","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41577-022-00694-4","volume":"22","author":"J Amersfoort","year":"2022","unstructured":"Amersfoort J, Eelen G, Carmeliet P. Immunomodulation by endothelial cells: partnering up with the immune system? Nat Rev Immunol. 2022;22(9):576\u201388.","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"2249_CR78","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.3390\/cancers13071724","volume":"13","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Ting KK, Coleman P, Qi Y, Chen J, Vadas M, et al. The tumour vasculature as a target to modulate leucocyte trafficking. Cancers. 2021;13(7):1724.","journal-title":"Cancers"},{"issue":"1","key":"2249_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/1423-0127-18-39","volume":"18","author":"L He","year":"2011","unstructured":"He L, Wang T, Gao Q, Zhao G, Huang Y, Yu L, et al. Stanniocalcin-1 promotes tumor angiogenesis through up-regulation of VEGF in gastric cancer cells. J Biomed Sci. 2011;18(1):39.","journal-title":"J Biomed Sci"},{"issue":"21","key":"2249_CR80","doi-asserted-by":"publisher","first-page":"7171","DOI":"10.1158\/1078-0432.CCR-04-0742","volume":"10","author":"JCABter Steege","year":"2004","unstructured":"Steege JCABter, Baeten CIM, Thijssen VLJL, Satijn SA, Verhoeven ICL, Hillen HFP, et al. Angiogenic profile of breast carcinoma determines leukocyte infiltration. Clin Cancer Res. 2004;10(21):7171\u20138.","journal-title":"Clin Cancer Res"},{"issue":"5482","key":"2249_CR81","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1126\/science.289.5482.1197","volume":"289","author":"BSt Croix","year":"2000","unstructured":"Croix BSt, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, et al. Genes expressed in human tumor endothelium. Science. 2000;289(5482):1197\u2013202.","journal-title":"Science"},{"issue":"4","key":"2249_CR82","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1158\/0008-5472.CAN-06-3700","volume":"67","author":"C Lu","year":"2007","unstructured":"Lu C, Bonome T, Li Y, Kamat AA, Han LY, Schmandt R, et al. Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma. Cancer Res. 2007;67(4):1757\u201368.","journal-title":"Cancer Res"},{"issue":"9","key":"2249_CR83","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1038\/s41401-023-01079-6","volume":"44","author":"SA Kov\u00e1cs","year":"2023","unstructured":"Kov\u00e1cs SA, Fekete JT, Gy\u0151rffy B. Predictive biomarkers of immunotherapy response with pharmacological applications in solid tumors. Acta Pharmacol Sin. 2023;44(9):1879\u201389.","journal-title":"Acta Pharmacol Sin"},{"issue":"5","key":"2249_CR84","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/s12276-020-0439-4","volume":"52","author":"KJ Choi","year":"2020","unstructured":"Choi KJ, Nam JK, Kim JH, Choi SH, Lee YJ. Endothelial-to-mesenchymal transition in anticancer therapy and normal tissue damage. Exp Mol Med. 2020;52(5):781\u201392.","journal-title":"Exp Mol Med"},{"issue":"3","key":"2249_CR85","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ccell.2020.03.002","volume":"37","author":"J Goveia","year":"2020","unstructured":"Goveia J, Rohlenova K, Taverna F, Treps L, Conradi LC, Pircher A, et al. An integrated gene expression landscape profiling approach to identify lung tumor endothelial cell heterogeneity and angiogenic candidates. Cancer Cell. 2020;37(3):421.","journal-title":"Cancer Cell"},{"key":"2249_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00367","volume":"8","author":"D Klein","year":"2018","unstructured":"Klein D. The tumor vascular endothelium as decision maker in cancer therapy. Front Oncol. 2018;8:367.","journal-title":"Front Oncol"},{"issue":"10","key":"2249_CR87","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/nri3064","volume":"11","author":"GT Motz","year":"2011","unstructured":"Motz GT, Coukos G. The parallel lives of angiogenesis and immunosuppression: cancer and other tales. Nat Rev Immunol. 2011;11(10):702\u201311.","journal-title":"Nat Rev Immunol"},{"key":"2249_CR88","doi-asserted-by":"publisher","first-page":"1063051","DOI":"10.3389\/fonc.2023.1063051","volume":"13","author":"JA Thomas","year":"2023","unstructured":"Thomas JA, Moly AGG, Xavier H, Suboj P, Ladha A, Gupta G, et al. Enhancement of immune surveillance in breast cancer by targeting hypoxic tumor endothelium: Can it be an immunological switch point? Front Oncol. 2023;13:1063051.","journal-title":"Front Oncol"},{"issue":"3","key":"2249_CR89","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/jcbfm.2009.240","volume":"30","author":"BD Semple","year":"2009","unstructured":"Semple BD, Kossmann T, Morganti-Kossmann MC. Role of chemokines in CNS health and pathology: a focus on the CCL2\/CCR2 and CXCL8\/CXCR2 networks. J Cereb Blood Flow Metab. 2009;30(3):459\u201373.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"2249_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01524-9","volume":"9","author":"C Zhou","year":"2023","unstructured":"Zhou C, Gao Y, Ding P, Wu T, Ji G. The role of CXCL family members in different diseases. Cell Death Discov. 2023;9(1):212.","journal-title":"Cell Death Discov"},{"key":"2249_CR91","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00085","volume":"10","author":"M Mussbacher","year":"2019","unstructured":"Mussbacher M, Salzmann M, Brostjan C, Hoesel B, Schoergenhofer C, Datler H, et al. Cell type-specific roles of NF-\u03baB linking inflammation and thrombosis. Front Immunol. 2019;10:85.","journal-title":"Front Immunol"},{"issue":"1","key":"2249_CR92","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10456-008-9094-4","volume":"11","author":"SP Tabruyn","year":"2008","unstructured":"Tabruyn SP, Griffioen AW. NF-\u03baB: a new player in angiostatic therapy. Angiogenesis. 2008;11(1):101\u20136.","journal-title":"Angiogenesis"},{"issue":"9","key":"2249_CR93","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1158\/1535-7163.MCT-09-0383","volume":"8","author":"SP Tabruyn","year":"2009","unstructured":"Tabruyn SP, M\u00e9met S, Av\u00e9 P, Verhaeghe C, Mayo KH, Struman I, et al. NF-\u03baB activation in endothelial cells is critical for the activity of angiostatic agents. Mol Cancer Ther. 2009;8(9):2645\u201354.","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"2249_CR94","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/onc.2011.233","volume":"31","author":"M Mura","year":"2012","unstructured":"Mura M, Swain RK, Zhuang X, Vorschmitt H, Reynolds G, Durant S, et al. Identification and angiogenic role of the novel tumor endothelial marker CLEC14A. Oncogene. 2012;31(3):293\u2013305.","journal-title":"Oncogene"},{"issue":"4","key":"2249_CR95","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/cjp2.176","volume":"6","author":"J Robinson","year":"2020","unstructured":"Robinson J, Whitworth K, Jinks E, Nagy Z, Bicknell R, Lee SP. An evaluation of the tumour endothelial marker CLEC14A as a therapeutic target in solid tumours. J Pathol Clin Res. 2020;6(4):308\u201319.","journal-title":"J Pathol Clin Res"},{"issue":"19","key":"2249_CR96","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.138808","volume":"5","author":"X Zhuang","year":"2020","unstructured":"Zhuang X, Maione F, Robinson J, Bentley M, Kaul B, Whitworth K, et al. CAR T cells targeting tumor endothelial marker CLEC14A inhibit tumor growth. JCI Insight. 2020;5(19):e138808.","journal-title":"JCI Insight"},{"issue":"3","key":"2249_CR97","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/1878-0261.12169","volume":"12","author":"T Kim","year":"2018","unstructured":"Kim T, Park CS, Jang J, Kim MR, Na H, Lee K, et al. Inhibition of VEGF-dependent angiogenesis and tumor angiogenesis by an optimized antibody targeting CLEC14a. Mol Oncol. 2018;12(3):356\u201372.","journal-title":"Mol Oncol"},{"issue":"1","key":"2249_CR98","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1006\/bbrc.2001.5737","volume":"288","author":"C Liu","year":"2001","unstructured":"Liu C, Shao ZM, Zhang L, Beatty P, Sartippour M, Lane T, et al. Human endomucin is an endothelial marker. Biochem Biophys Res Commun. 2001;288(1):129\u201336.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"2249_CR99","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1046\/j.1523-1747.2002.19647.x","volume":"119","author":"A Kuhn","year":"2002","unstructured":"Kuhn A, Brachtendorf G, Kurth F, Sonntag M, Samulowitz U, Metze D, et al. Expression of endomucin, a novel endothelial sialomucin, in normal and diseased human skin. J Invest Dermatol. 2002;119(6):1388\u201393.","journal-title":"J Invest Dermatol"},{"issue":"S1","key":"2249_CR100","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1096\/fasebj.29.1_supplement.418.1","volume":"29","author":"C Park-Windhol","year":"2015","unstructured":"Park-Windhol C, Yang J, Primo V, Ng Y, Saint-Geniez M, D\u2019Amore P. Endomucin plays a role in retinal vascular development and in VEGF-induced endothelial cell migration, growth, and morphogenesis. FASEB J. 2015;29(S1):418.","journal-title":"FASEB J"},{"issue":"S1","key":"2249_CR101","first-page":"lb506","volume":"31","author":"PA D\u2019Amore","year":"2017","unstructured":"D\u2019Amore PA, Park-Windhol CA, Saint-Geniez M. Endomucin is necessary for pathologic retinal neovascularization in vivo. FASEB J. 2017;31(S1):lb506.","journal-title":"FASEB J"},{"issue":"4","key":"2249_CR102","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/ame2.12142","volume":"3","author":"G Zhang","year":"2020","unstructured":"Zhang G, Yang X, Gao R. Research progress on the structure and function of endomucin. Anim Model Exp Med. 2020;3(4):325\u20139.","journal-title":"Anim Model Exp Med"},{"issue":"1","key":"2249_CR103","doi-asserted-by":"publisher","first-page":"10363","DOI":"10.1038\/ncomms10363","volume":"7","author":"A Zahr","year":"2015","unstructured":"Zahr A, Alcaide P, Yang J, Jones A, Gregory M, Paz Dela NG, et al. Endomucin prevents leukocyte-endothelial cell adhesion and has a critical role under resting and inflammatory conditions. Nat Commun. 2015;7(1):10363.","journal-title":"Nat Commun"},{"key":"2249_CR104","doi-asserted-by":"crossref","unstructured":"Hu Z, Cano I, Saint\u2010Geniez M, Ng YE, D\u2019Amore P. EMCN knockout leads to increased monocyte infiltration in kidney and albuminuria in mice. FASEB J. 2022;36(S1).","DOI":"10.1096\/fasebj.2022.36.S1.R2538"},{"issue":"1","key":"2249_CR105","doi-asserted-by":"publisher","first-page":"T11","DOI":"10.1530\/JME-17-0254","volume":"61","author":"LA Bach","year":"2018","unstructured":"Bach LA. 40 years of IGF1: IGF-binding proteins. J Mol Endocrinol. 2018;61(1):T11-28.","journal-title":"J Mol Endocrinol"},{"issue":"2","key":"2249_CR106","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/sj.bjc.6605141","volume":"101","author":"AJ Ryan","year":"2009","unstructured":"Ryan AJ, Napoletano S, Fitzpatrick PA, Currid CA, O\u2019Sullivan NC, Harmey JH. Expression of a protease-resistant insulin-like growth factor-binding protein-4 inhibits tumour growth in a murine model of breast cancer. Br J Cancer. 2009;101(2):278\u201386.","journal-title":"Br J Cancer"},{"issue":"1","key":"2249_CR107","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1038\/s41598-021-81914-0","volume":"11","author":"K Kr\u00fcger","year":"2021","unstructured":"Kr\u00fcger K, Silwal-Pandit L, Wik E, Straume O, Stefansson IM, Borgen E, et al. Baseline microvessel density predicts response to neoadjuvant bevacizumab treatment of locally advanced breast cancer. Sci Rep. 2021;11(1):3388.","journal-title":"Sci Rep"},{"issue":"3","key":"2249_CR108","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s10549-011-1740-7","volume":"130","author":"H Nalwoga","year":"2011","unstructured":"Nalwoga H, Arnes JB, Stefansson IM, Wabinga H, Foulkes WD, Akslen LA. Vascular proliferation is increased in basal-like breast cancer. Breast Cancer Res Treat. 2011;130(3):1063\u201371.","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"2249_CR109","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.ajpath.2017.01.014","volume":"187","author":"A Imai","year":"2017","unstructured":"Imai A, Toriyama Y, Iesato Y, Hirabayashi K, Sakurai T, Kamiyoshi A, et al. Adrenomedullin suppresses vascular endothelial growth factor\u2013induced vascular hyperpermeability and inflammation in retinopathy. Am J Pathol. 2017;187(5):999\u20131015.","journal-title":"Am J Pathol"},{"key":"2249_CR110","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1233073","volume":"14","author":"Z Yang","year":"2023","unstructured":"Yang Z, Li H, Wu P, Li Q, Yu C, Wang D, et al. Multi-biological functions of intermedin in diseases. Front Physiol. 2023;14:1233073.","journal-title":"Front Physiol"},{"key":"2249_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2020.170347","volume":"131","author":"JP Fischer","year":"2020","unstructured":"Fischer JP, Els-Heindl S, Beck-Sickinger AG. Adrenomedullin: current perspective on a peptide hormone with significant therapeutic potential. Peptides. 2020;131:170347.","journal-title":"Peptides"},{"key":"2249_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygcen.2021.113752","volume":"306","author":"M Ogoshi","year":"2021","unstructured":"Ogoshi M, Takahashi M, Aoyagi K, Ukena K, Aizawa S, Takeuchi H, et al. Adrenomedullin 2 and 5 activate the calcitonin receptor-like receptor (clr): receptor activity-modifying protein 3 (ramp3) receptor complex in Xenopus tropicalis. Gen Comp Endocrinol. 2021;306:113752.","journal-title":"Gen Comp Endocrinol"},{"issue":"7","key":"2249_CR113","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1161\/CIRCULATIONAHA.112.000756","volume":"127","author":"T Koyama","year":"2013","unstructured":"Koyama T, Ochoa-Callejero L, Sakurai T, Kamiyoshi A, Ichikawa-Shindo Y, Iinuma N, et al. Vascular endothelial adrenomedullin-RAMP2 system is essential for vascular integrity and organ homeostasis. Circulation. 2013;127(7):842\u201353.","journal-title":"Circulation"},{"issue":"5","key":"2249_CR114","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70460","volume":"29","author":"Z Xuan","year":"2025","unstructured":"Xuan Z, Hu H, Xu J, Ling X, Zhang L, Li W, et al. Adrenomedullin inhibits the efficacy of combined immunotherapy and targeted therapy in biliary tract cancer by disrupting endothelial cell functions. J Cell Mol Med. 2025;29(5):e70460.","journal-title":"J Cell Mol Med"},{"issue":"1\u20133","key":"2249_CR115","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.regpep.2010.08.003","volume":"166","author":"D Jin","year":"2011","unstructured":"Jin D, Otani K, Yamahara K, Ikeda T, Nagaya N, Kangawa K. Adrenomedullin reduces expression of adhesion molecules on lymphatic endothelial cells. Regul Pept. 2011;166(1\u20133):21\u20137.","journal-title":"Regul Pept"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-026-02249-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02249-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02249-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:14:33Z","timestamp":1781637273000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13058-026-02249-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":115,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2249"],"URL":"https:\/\/doi.org\/10.1186\/s13058-026-02249-0","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"3 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"69"}}